320MO A phase I clinical trial of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant MSS metastatic colorectal cancer (mCRC)
M.G. Fakih, Jaideep Sandhu, D. Lim, S.M. Li, C. Wang
Topics & Concepts
MedicineRegorafenibNivolumabIpilimumabColorectal cancerOncologyChemotherapyInternal medicinePhases of clinical researchCancerImmunotherapyColorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics